These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12956548)

  • 21. Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors.
    White JR; Veltri MA; Fackler JC
    Pediatr Crit Care Med; 2005 Jan; 6(1):25-32. PubMed ID: 15636655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examining the effectiveness of 2 solutions used to flush capped pediatric peripheral intravenous catheters.
    White ML; Crawley J; Rennie EA; Lewandowski LA
    J Infus Nurs; 2011; 34(4):260-70. PubMed ID: 21734522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis.
    Clavel A; Boulaméry A; Bosdure E; Luc C; Lanteaume A; Gorincour G; Stremler-Lebel N; Sarles J; Andrieu V; Dubus JC
    J Cyst Fibros; 2007 Apr; 6(2):137-43. PubMed ID: 16839826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of in-line filtration on tobramycin delivery.
    Elenbaas JK; Lander RD; Elenbaas RM
    Drug Intell Clin Pharm; 1985 Feb; 19(2):122-5. PubMed ID: 3882376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
    Stelmach I; Korzeniewska A; Stelmach W
    Respiration; 2008; 75(2):178-81. PubMed ID: 17435382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.
    Massie J; Cranswick N
    J Paediatr Child Health; 2006 Oct; 42(10):601-5. PubMed ID: 16972966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
    Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
    Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia.
    Croisier D; Martha B; Piroth L; Chavanet P
    Int J Antimicrob Agents; 2008 Dec; 32(6):494-8. PubMed ID: 18804348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of linezolid in children.
    Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An IV therapy teaching tool for children.
    Thompson V
    Pediatr Nurs; 1994; 20(4):351-5. PubMed ID: 7885745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survey of nursing practice related to decanting intravenous solutions.
    Sulzbach LM; Munro BH
    Heart Lung; 1991 Nov; 20(6):624-30. PubMed ID: 1960066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis.
    Glass S; Plant ND; Spencer DA
    J Cyst Fibros; 2005 Dec; 4(4):221-5. PubMed ID: 16239129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled tobramycin-associated hearing loss in an adolescent with renal failure.
    Patatanian L
    Pediatr Infect Dis J; 2006 Mar; 25(3):276-8. PubMed ID: 16511399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients.
    Badia JR; Soy D; Adrover M; Ferrer M; Sarasa M; Alarcón A; Codina C; Torres A
    J Antimicrob Chemother; 2004 Aug; 54(2):508-14. PubMed ID: 15215224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tobramycin by inhalation].
    Taéron C
    Rev Infirm; 2006 Mar; (119):35-6. PubMed ID: 16625786
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous dextrose during outpatient rehydration in pediatric gastroenteritis.
    Levy JA; Bachur RG
    Acad Emerg Med; 2007 Apr; 14(4):324-30. PubMed ID: 17296801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms.
    Chiu AG; Antunes MB; Palmer JN; Cohen NA
    J Antimicrob Chemother; 2007 Jun; 59(6):1130-4. PubMed ID: 17405780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of a safer approach to intravenous drug infusions: failure mode effects analysis.
    Apkon M; Leonard J; Probst L; DeLizio L; Vitale R
    Qual Saf Health Care; 2004 Aug; 13(4):265-71. PubMed ID: 15289629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing delays in medication administration for patients transferred from the hospital to the nursing home: a pilot quality improvement project.
    Ward KT; Bates-Jensen B; Eslami MS; Whiteman E; Dattoma L; Friedman JL; DeCastro Mariano J; Moore AA
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):205-11. PubMed ID: 19028376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Errors in the administration of intravenous medication in Brazilian hospitals.
    Anselmi ML; Peduzzi M; Dos Santos CB
    J Clin Nurs; 2007 Oct; 16(10):1839-47. PubMed ID: 17880472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.